Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sapience Therapeutics

Sapience Therapeutics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
7 INVESTORS
Description

Provider of biotechnology services focused on discovering and developing peptide-based therapeutics for major unmet medical needs such as high mortality cancers. The company identifies promising targets through a deep understanding of the transcriptional regulation of oncogenic or immune-modulatory proteins and incorporates multiple approaches to generate initial hits which are then optimized based on decades of experience working with peptide and protein therapeutics, enabling doctors and medical professionals to fight, tackle and possibly cure many deadly medical conditions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 500 Mamaroneck Avenue
  • Suite 320
  • Harrison, NY 10528
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sapience Therapeutics’s full profile, request a free trial.

Sapience Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jul-2018 000.00 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 12-Jul-2016 000.00 000.00 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Sapience Therapeutics Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000 00000
00000 0000000000 Formerly VC-backed Miramar, FL 00 00000 000000&0 00000
000000 Formerly VC-backed San Diego, CA 000 000.00 000000&0 000.00
00000000 000000000 Venture Capital-Backed Research Triangle Park, NC 00000 000000000 00000
000000000 Private Equity-Backed Gaithersburg, MD 000.00 0000000 0000 000.00
To view this company’s complete list of competitors, request access »

Sapience Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
Columbia Technology Ventures University Minority 000 0000 000000 0
Connectivity Ventures Fund Venture Capital Minority 000 0000 000000 0
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Sapience Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Barry Kappel Ph.D Founder, Board Member, Chief Executive Officer and President

Sapience Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Barry Kappel Ph.D Sapience Therapeutics Founder, Board Member, Chief Executive Officer and President 000 0000
Christian Schade Self Board Member 000 0000
David Scheinberg Ph.D Self Board Member 000 0000
Howard Pien Self Chairman 000 0000
Isaac Blech Self Vice Chairman 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »